Skip to main content
Signal8

SPO Global Inc. (SPOM)

Established in 2006 and headquartered in Jinan, China, Gerpang Healthcare Group operates as a bio-pharmaceutical enterprise. The company focuses on developing and marketing a diverse range of products, including genetically coated stents, vaccines for the Hepatitis B virus (HBV), monoclonal antibodies designed to detect male infertility, functional foods targeting cognitive disorders, and polypeptide-based probiotics.

Sector: Software - Application

Industry: Software - Application

SPO Global Inc. logo

SPO Global Inc.

OTC:SPOMTechnology
$0.0003
CLOSED
Mkt Cap$475K
EV-
Float213.35M
O/S1.58B
VOL12K sh
$ Vol$4
RVOL0.03×
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
SPO Global Inc. logoOTC:SPOMClosed$0.0003
FormDescription
    SPO Global Inc. (SPOM) SEC Filings: 10-K, 10-Q, 8-K, Form 4 | Signal8